Yoshiaki Nishiyama,Nobuaki Nishiyama. Survival risk heterogeneity among patients with NSCLC receiving nivolumab visualized by risk scores generated from deep learning method DeepSurv using tumor gene mutations. 2026
Yoshiaki Nishiyama, Akitaka Higashi, Fumikazu Miwakeichi, Nobuaki Nishiyama. Validation of Transcription Factors Underlying the Control of CD8+ T Cell Differentiation Along the Paths of Exhaustion and Senescence in Acute Myeloid Leukemia Using an Artificial Neural Network Model. Diseases & Research. 2025. 5. 4. 181-187
Yutaka Saikawa, Toshihiko Komatsuzaki, Nobuaki Nishiyama, Toshihisa Hatta. Cellular automata modelling of leukaemic stem cell dynamics in acute myeloid leukaemia: insights into predictive outcomes and targeted therapies. Royal Society Open Science. 2025. 12. 241202
Nobuaki Nishiyama, Peter Ruoff, Juan Carlos Jimenez, Fumikazu Miwakeichi, Yoshiaki Nishiyama, Tsuyoshi Yata. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation. BioSystems. 2023. 227. 104889-104889
Ruoff P, Nishiyama N. Frequency switching between oscillatory homeostats and the regulation of p53. PLoS ONE. 2020. 15. 5. e0227786
